ARS
ABBV icon

Adirondack Retirement Specialists’s AbbVie ABBV Stock Holding History

Adirondack Retirement Specialists’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-346
Closed -$46.6K – 25
2023
Q2 		$46.6K Hold
346
– – 0.04% 35
2023
Q1 		$55.3K Hold
346
– – 0.05% 41
2022
Q4 		$55.9K Hold
346
– – 0.06% 28
2022
Q3 		$46K Buy
+346
New +$49.7K 0.04% 32

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Adirondack Retirement Specialists's ABBV Position: Q3 2023 in Review

Adirondack Retirement Specialists sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 346 shares — an estimated $46.6K sold.

Adirondack Retirement Specialists first reported a position in ABBV in Q3 2022 and held it in 4 quarters. The position peaked at $55.9K in Q4 2022. 3,108 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

  • Adirondack Retirement Specialists reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
  • Adirondack Retirement Specialists sold 346 AbbVie shares in Q3 2023, an estimated $46.6K.
  • Adirondack Retirement Specialists first reported a position in AbbVie in Q3 2022 and held it in 4 quarters.
  • Adirondack Retirement Specialists's AbbVie position peaked at $55.9K in Q4 2022.
  • 3,108 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Adirondack Retirement Specialists's 13F filing for Q3 2023, filed 24 Oct 2023.